Search Results - "SVATEK, Robert S"

Efficacy of Bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis by Boehm, Brock E, Cornell, John E, Wang, Hanzhang, Mukherjee, Neelam, Oppenheimer, Jacob S, Svatek, Robert S

“…Purpose We sought to determine the efficacy of genetically distinct bacillus Calmette-Guérin strains in preventing disease recurrence in patients with…”
Get full text

Identification of Differential Tumor Subtypes of T1 Bladder Cancer by Robertson, A. Gordon, Groeneveld, Clarice S., Jordan, Brian, Lin, Xiquo, McLaughlin, Kimberly A., Das, Arighno, Fall, Leigh Ann, Fantini, Damiano, Taxter, Timothy J., Mogil, Lauren S., Lindskrog, Sia Viborg, Dyrskjøt, Lars, McConkey, David J., Svatek, Robert S., de Reyniès, Aurélien, Castro, Mauro A.A., Meeks, Joshua J.

“…Stage T1 bladder cancers have the highest progression and recurrence rates of all non–muscle-invasive bladder cancers (NMIBCs). Most T1 cancers are treated…”
Get full text

Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial by Lee, Cheryl T, Chang, Sam S, Kamat, Ashish M, Amiel, Gilad, Beard, Timothy L, Fergany, Amr, Karnes, R. Jeffrey, Kurz, Andrea, Menon, Venu, Sexton, Wade J, Slaton, Joel W, Svatek, Robert S, Wilson, Shandra S, Techner, Lee, Bihrle, Richard, Steinberg, Gary D, Koch, Michael

“…Abstract Background Radical cystectomy (RC) for bladder cancer is frequently associated with delayed gastrointestinal (GI) recovery that prolongs hospital…”
Get full text

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers by Kamat, Ashish M, Hegarty, Paul K, Gee, Jason R, Clark, Peter E, Svatek, Robert S, Hegarty, Nicholas, Shariat, Shahrokh F, Xylinas, Evanguelos, Schmitz-Dräger, Bernd J, Lotan, Yair, Jenkins, Lawrence C, Droller, Michael, van Rhijn, Bas W, Karakiewicz, Pierre I

“…Abstract Context and objective To present a summary of the 2nd International Consultation on Bladder Cancer recommendations on the screening, diagnosis, and…”
Get full text

Definition, Incidence, Risk Factors, and Prevention of Paralytic Ileus Following Radical Cystectomy: A Systematic Review by Ramirez, Jorge A, McIntosh, Andrew G, Strehlow, Robert, Lawrence, Valerie A, Parekh, Dipen J, Svatek, Robert S

“…Abstract Context Postoperative paralytic ileus (POI) has profound clinical consequences because it represents a substantial burden on both patients and health…”
Get full text

Chemoradiation Vs Radical Cystectomy for Muscle-invasive Bladder Cancer: A Propensity Score-weighted Comparative Analysis Using the National Cancer Database by Kaushik, Dharam, Wang, Hanzhang, Michalek, Joel, Liss, Michael A., Liu, Qianqian, Jha, Richa Priya, Svatek, Robert S., Mansour, Ahmed M.

“…To address the overarching question whether chemoradiation therapy (CMT) offers overall survival (OS) similar to that of radical cystectomy (RC) in…”
Get full text

Role of immunotherapy in bacillus Calmette–Guérin-unresponsive non–muscle invasive bladder cancer by Mukherjee, Neelam, Svatek, Robert S., Mansour, Ahmed M.

“…Intravesical instillation of live attenuated bacillus Calmette–Guérin (BCG) is the gold standard for patients with intermediate- and high-risk…”
Get full text

Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD–SIU joint consultation on bladder cancer by Fernández, Mario I., Brausi, Maurizio, Clark, Peter E., Cookson, Michael S., Grossman, H. Barton, Khochikar, Makarand, Kiemeney, Lambertus A., Malavaud, Bernard, Sanchez-Salas, Rafael, Soloway, Mark S., Svatek, Robert S., Vikram, Raghunandan, Vrieling, Alina, Kamat, Ashish M.

“…Purpose To update current recommendations on prevention, screening, diagnosis, and evaluation of bladder cancer (BC) based on a thorough assessment of the most…”
Get full text

Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model by Padrón, Álvaro, Hurez, Vincent, Gupta, Harshita B., Clark, Curtis A., Pandeswara, Sri Lakshmi, Yuan, Bin, Svatek, Robert S., Turk, Mary Jo, Drerup, Justin M., Li, Rong, Curiel, Tyler J.

“…Cancer immunotherapy has shown remarkable recent progress. Immune checkpoint blocking antibodies have become the most successful anti-cancer agent class ever…”
Get full text

Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients by Novara, Giacomo, Svatek, Robert S, Karakiewicz, Pierre I, Skinner, Eila, Ficarra, Vincenzo, Fradet, Yves, Lotan, Yair, Isbarn, Hendrik, Capitanio, Umberto, Bastian, Patrick J, Kassouf, Wassim, Fritsche, Hans-Martin, Izawa, Jonathan I, Tilki, Derya, Dinney, Colin P, Lerner, Seth P, Schoenberg, Mark, Volkmer, Bjoern G, Sagalowsky, Arthur I, Shariat, Shahrokh F

“…We evaluated the association of soft tissue surgical margins with characteristics and outcomes of patients treated with radical cystectomy for urothelial…”
Get more information

A comparative analysis of radical cystectomy with perioperative chemotherapy, chemoradiation therapy, or systemic therapy in patients with clinically advanced node-positive bladder cancer (cN2/N3) by Garg, Harshit, Bhandari, Mukund, Dursun, Furkan, Liss, Michael A, Kaushik, Dharam, Svatek, Robert S, Mansour, Ahmed M

“…The management of non-metastatic clinically advanced lymph nodal (cN2/N3) bladder cancer (Stage IIIB) could involve radical cystectomy, chemoradiation, or…”
Get full text

Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors by Murray, Clare E, Kornepati, Anand V R, Ontiveros, Carlos, Liao, Yiji, de la Peña Avalos, Bárbara, Rogers, Cody M, Liu, Zexuan, Deng, Yilun, Bai, Haiyan, Kari, Suresh, Padron, Alvaro S, Boyd, Jacob T, Reyes, Ryan, Clark, Curtis A, Svatek, Robert S, Li, Rong, Hu, Yanfen, Wang, Meiling, Conejo-Garcia, José R, Byers, Lauren A, Ramkumar, Kavya, Sood, Anil K, Lee, Jung-Min, Burd, Christin E, Vadlamudi, Ratna K, Gupta, Harshita B, Zhao, Weixing, Dray, Eloïse, Sung, Patrick, Curiel, Tyler J

“…Aside from the canonical role of PDL1 as a tumour surface-expressed immune checkpoint molecule, tumour-intrinsic PDL1 signals regulate non-canonical…”
Get full text

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy by Zhang, Deyi, Reyes, Ryan M., Osta, Erica, Kari, Suresh, Gupta, Harshita B., Padron, Alvaro S., Kornepati, Anand V. R., Kancharla, Aravind, Sun, Xiujie, Deng, Yilun, Wu, Bogang, Vadlamudi, Ratna, Li, Rong, Svatek, Robert S., Curiel, Tyler J.

“…Tumor cell‐intrinsic programmed death‐ligand 1 (PD‐L1) signals mediate immunopathologic effects in breast, colon, and ovarian cancers and in melanomas, but…”
Get full text

KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer by Mukherjee, Neelam, Ji, Niannian, Tan, Xi, Chen, Chun‐Liang, Noel, Onika D. V., Rodriguez‐Padron, Maria, Lin, Chun‐Lin, Alonzo, David G., Huang, Tim H., Svatek, Robert S.

“…Background Bladder tumor‐infiltrating CD56bright NK cells are more tumor cytotoxic than their CD56dim counterparts. Identification of NK cell subsets is…”
Get full text

Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort by Krabbe, Laura-Maria, M.D, Svatek, Robert S., M.D, Shariat, Shahrokh F., M.D, Messing, Edward, M.D, Lotan, Yair, M.D

“…Abstract Purpose Bladder cancer (BC) screening is not accepted in part owing to low overall incidence. We used the Prostate, Lung, Colorectal, and Ovarian…”
Get full text

Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial by Ji, Niannian, Mukherjee, Neelam, Morales, Edwin E., Tomasini, Maggie E., Hurez, Vincent, Curiel, Tyler J., Abate, Getahun, Hoft, Dan F., Zhao, Xiang-Ru, Gelfond, Jon, Maiti, Sourindra, Cooper, Laurence J.N., Svatek, Robert S.

“…Background: Intravesical bacillus Calmette-Guérin (BCG) is the gold standard immunologic agent for treating patients with high-grade non-muscle invasive…”
Get full text

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER? by Patel, Hiten D, Puligandla, Maneka, Shuch, Brian M, Leibovich, Bradley C, Kapoor, Anil, Master, Viraj A, Drake, Charles G, Heng, Daniel Yc, Lara, Primo N, Choueiri, Toni K, Maskens, Deborah, Singer, Eric A, Eggener, Scott E, Svatek, Robert S, Stadler, Walter M, Cole, Suzanne, Signoretti, Sabina, Gupta, Rajan T, Michaelson, Marc Dror, McDermott, David F, Cella, David, Wagner, Lynne I, Haas, Naomi B, Carducci, Michael A, Harshman, Lauren C, Allaf, Mohamad E

“…Patients with high-risk renal cell carcinoma (RCC) experience high rates of recurrence despite definitive surgical resection. Recent trials of adjuvant…”
Get full text

Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial by Svatek, Robert S, Zhao, Xiang Ru, Morales, Edwin E, Jha, Mithilesh K, Tseng, Timothy Y, Hugen, Cory M, Hurez, Vincent, Hernandez, Javier, Curiel, Tyler J

“…To determine the safety and toxicities of sequential MMC (mitomycin C) + BCG (bacillus Calmette-Guérin) in patients with non-muscle-invasive bladder cancer…”
Get full text

What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up by Buteau, Anna, B.S, Seideman, Casey A., M.D, Svatek, Robert S., M.D, Youssef, Ramy F., M.D, Chakrabarti, Gaurab, B.S, Reed, Gary, M.D, Bhat, Deepa, M.D, Lotan, Yair, M.D

“…Abstract Background To determine whether patients found to have hematuria by their primary care physicians are evaluated according to best practice policy…”
Get full text

Impact of rural residence on the presentation, management and survival of patients with non-metastatic muscle-invasive bladder carcinoma by Dursun, Furkan, Elshabrawy, Ahmed, Wang, Hanzhang, Kaushik, Dharam, Liss, Michael A., Svatek, Robert S., Gore, John L., Mansour, Ahmed M.

“…PURPOSETo assess the impact of rural and remote residence on the receipt of guidelines-recommended treatment, quality of treatment and overall survival (OS) in…”
Get full text